respiratory diseases
Recently Published Documents


TOTAL DOCUMENTS

4978
(FIVE YEARS 1916)

H-INDEX

73
(FIVE YEARS 18)

2022 ◽  
Vol 81 ◽  
pp. 100880
Author(s):  
Sarah Basin ◽  
Simon Valentin ◽  
Arnaud Maurac ◽  
Mathias Poussel ◽  
Benjamin Pequignot ◽  
...  

2022 ◽  
Vol 74 ◽  
pp. 104-109
Author(s):  
Esther H Roh ◽  
Catherine A Fromen ◽  
Millicent O Sullivan
Keyword(s):  

2022 ◽  
Vol 155 ◽  
pp. 111727
Author(s):  
Hilda Fahlena ◽  
Rudy Kusdiantara ◽  
Nuning Nuraini ◽  
Edy Soewono

2022 ◽  
Vol 806 ◽  
pp. 150352
Author(s):  
Jennifer Fishe ◽  
Yi Zheng ◽  
Tianchen Lyu ◽  
Jiang Bian ◽  
Hui Hu

Author(s):  
Wojciech Nazar ◽  
Marek Niedoszytko

According to the World Bank Group, 36 of the 50 most polluted cities in the European Union are in Poland. Thus, ambient air pollution and its detrimental health effects are a matter of immense importance in Poland. This narrative review aims to analyse current findings on air pollution and health in Poland, with a focus on respiratory diseases, including COVID-19, as well as the Poles’ awareness of air pollution. PubMed, Scopus and Google Scholar databases were searched. In total, results from 71 research papers were summarized qualitatively. In Poland, increased air pollution levels are linked to increased general and respiratory disease mortality rates, higher prevalence of respiratory diseases, including asthma, lung cancer and COVID-19 infections, reduced forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). The proximity of high traffic areas exacerbates respiratory health problems. People living in more polluted regions (south of Poland) and in the winter season have a higher level of air pollution awareness. There is an urgent need to reduce air pollution levels and increase public awareness of this threat. A larger number of multi-city studies are needed in Poland to consistently track the burden of diseases attributable to air pollution.


2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Jianjun Bai ◽  
Yudi Zhao ◽  
Donghui Yang ◽  
Yudiyang Ma ◽  
Chuanhua Yu

Abstract Background As the emerging economies, the BRICS (Brazil, Russia, India, China, and South Africa) shared 61.58% of the global chronic respiratory diseases (CRD) deaths in 2017. This study aimed to assess the secular trends in CRD mortality and explore the effects of age, period, and cohort across main BRICS countries. Methods Data were obtained from the Global Burden of Disease Study (GBD) 2019 and analyzed using the age-period-cohort (APC) model to estimate period and cohort effects between 1990 and 2019. The net drifts, local drifts, longitudinal age curves, period/cohort rate ratios (RRs) were obtained through the APC model. Results In 2019, the CRD deaths across the BRICS were 2.39 (95%UI 1.95 to 2.84) million, accounting for 60.07% of global CRD deaths. Chronic obstructive pulmonary disease (COPD) and asthma remained the leading causes of CRD deaths. The age-standardized mortality rates (ASMR) have declined across the BRICS since 1990, with the most apparent decline in China. Meanwhile, the downward trends in CRD death counts were observed in China and Russia. The overall net drifts per year were obvious in China (-5.89%; -6.06% to -5.71%), and the local drift values were all below zero in all age groups for both sexes. The age effect of CRD presented increase with age, and the period and cohort RRs were following downward trends over time across countries. Similar trends were observed in COPD and asthma. The improvement of CRD mortality was the most obvious in China, especially in period and cohort effects. While South Africa showed the most rapid increase with age across all CRD categories, and the period and cohort effects were flat. Conclusions BRICS accounted for a large proportion of CRD deaths, with China and India alone contributing more than half of the global CRD deaths. However, the declines in ASMR and improvements of period and cohort effects have been observed in both sexes and all age groups across main BRICS countries. China stands out for its remarkable reduction in CRD mortality and its experience may help reduce the burden of CRD in developing countries.


2022 ◽  
Vol 8 ◽  
Author(s):  
Simin Li ◽  
Wanchen Ning ◽  
Wei Wang ◽  
Dirk Ziebolz ◽  
Aneesha Acharya ◽  
...  

Background: This systematic review evaluates the oral health-related quality of life (OHRQoL) of patients with chronic respiratory diseases.Methods: A systematic literature search was performed based on the PubMed, Medline, Web of Science, and Scopus, using the search terms: “oral health-related quality of life” and “respiratory disease” or “lung” and “oral health-related quality of life.” Full-text articles published until June 30, 2021 and reporting any OHRQoL measurement in children or adults with a chronic respiratory disease or condition were included and analyzed qualitatively.Results: A total of seven out of 44 studies were included, of which four studies examined adults and three studies investigated children. The respective diseases were chronic obstructive pulmonary disease (COPD) (n = 2), sleep apnea (n = 2), severe asthma (n = 1), cystic fibrosis (n = 1), and lung transplantation (n = 1). Four studies confirmed a worse OHRQoL in the respiratory diseased group compared to healthy controls. The overall OHRQoL was reduced in the included studies. Oral health, health-related quality of life, and disease-related parameters were rarely examined with regard to OHRQoL.Conclusion: Patients with chronic respiratory diseases show a reduced OHRQoL. Oral health should be fostered in these individuals to support their OHRQoL.


Nanomedicine ◽  
2022 ◽  
Author(s):  
Bikash Manandhar ◽  
Keshav Raj Paudel ◽  
Nisha Panth ◽  
Philip Hansbro ◽  
Brian G Oliver ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document